|
[1]
|
Targeted biomarkers of progression in chronic kidney disease
Clinica Chimica Acta,
2022
DOI:10.1016/j.cca.2022.08.025
|
|
|
|
|
[2]
|
Targeted biomarkers of progression in chronic kidney disease
Clinica Chimica Acta,
2022
DOI:10.1016/j.cca.2022.08.025
|
|
|
|
|
[3]
|
Evaluation of hepatocyte growth factor as a local acute phase response marker in the bowel: The clinical impact of a rapid diagnostic test for immediate identification of acute bowel inflammation
Cytokine,
2015
DOI:10.1016/j.cyto.2014.07.255
|
|
|
|
|
[4]
|
Dynamic changes of early-stage aortic lipid deposition in chronic renal failure rats and effects of decorin gene therapy
Experimental and Therapeutic Medicine,
2015
DOI:10.3892/etm.2014.2106
|
|
|
|
|
[5]
|
Hepatocyte growth factor in cerebrospinal fluid differentiates community-acquired or nosocomial septic meningitis from other causes of pleocytosis
Fluids and Barriers of the CNS,
2015
DOI:10.1186/s12987-015-0020-z
|
|
|
|
|
[6]
|
High Concentration but Low Activity of Hepatocyte Growth Factor in Periodontitis
Journal of Periodontology,
2014
DOI:10.1902/jop.2013.130003
|
|
|
|
|
[7]
|
High Concentration but Low Activity of Hepatocyte Growth Factor in Periodontitis
Journal of Periodontology,
2014
DOI:10.1902/jop.2013.130003
|
|
|
|
|
[8]
|
Fibroblast Growth Factor 23, Hepatocyte Growth Factor, Interleukin‐6, High‐Sensitivity C‐Reactive Protein and Soluble Urokinase Plasminogen Activator Receptor. Inflammation Markers in Chronic Haemodialysis Patients?
Scandinavian Journal of Immunology,
2013
DOI:10.1111/sji.12082
|
|
|
|
|
[9]
|
A methachromatic-based experimental model for identification of bowel as the focus of an acute inflammation
Open Journal of Gastroenterology,
2013
DOI:10.4236/ojgas.2013.31007
|
|
|
|
|
[10]
|
Differences in the expression of hepatocyte growth factor in acute and chronic bowel inflammation—Implications for diagnosis?
Advances in Bioscience and Biotechnology,
2013
DOI:10.4236/abb.2013.48A2006
|
|
|
|
|
[11]
|
Fibroblast Growth Factor 23, Hepatocyte Growth Factor, Interleukin-6, High-Sensitivity C-Reactive Protein and Soluble Urokinase Plasminogen Activator Receptor. Inflammation Markers in Chronic Haemodialysis Patients?
Scandinavian Journal of Immunology,
2013
DOI:10.1111/sji.12082
|
|
|
|